WO2008156725A3 - Methods for inhibiting cartilage mineralization - Google Patents

Methods for inhibiting cartilage mineralization Download PDF

Info

Publication number
WO2008156725A3
WO2008156725A3 PCT/US2008/007485 US2008007485W WO2008156725A3 WO 2008156725 A3 WO2008156725 A3 WO 2008156725A3 US 2008007485 W US2008007485 W US 2008007485W WO 2008156725 A3 WO2008156725 A3 WO 2008156725A3
Authority
WO
WIPO (PCT)
Prior art keywords
subject
methods
articular cartilage
pthrp
administering
Prior art date
Application number
PCT/US2008/007485
Other languages
French (fr)
Other versions
WO2008156725A2 (en
Inventor
Helen Lu
Jie Jiang
Original Assignee
Univ Columbia
Helen Lu
Jie Jiang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia, Helen Lu, Jie Jiang filed Critical Univ Columbia
Publication of WO2008156725A2 publication Critical patent/WO2008156725A2/en
Publication of WO2008156725A3 publication Critical patent/WO2008156725A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3612—Cartilage, synovial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A61L27/3654—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3817—Cartilage-forming cells, e.g. pre-chondrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/06—Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/37—Parathyroid hormone [PTH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/395—Thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/10—Mineral substrates
    • C12N2533/12—Glass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers

Abstract

Methods and apparatuses are provided for inhibiting articular cartilage mineralization in a subject comprising administering to articular cartilage of the subject an amount of a functional domain of parathyroid hormone- related peptide (PTHrP). In addition, methods and apparatuses for preventing or treating osteoarthritis in a subject comprising administering to articular cartilage of the subject a prophylactically or therapeutically effective amount of a functional domain of parathyroid hormone- related peptide (PTHrP), respectively, are provided. Also, methods and apparatuses for promoting articular cartilage repair in a subject comprising comprising administering to articular cartilage of the subject an effective amount functional domain of parathyroid hormone-related peptide (PTHrP) are provided. Further, methods for diminishing damaging effects of physical activity on a joint in a subject comprising administering to articular cartilage of the subject an amount of a functional domain of parathyroid hormone-related peptide (PTHrP) are provided.
PCT/US2008/007485 2007-06-12 2008-06-16 Methods for inhibiting cartilage mineralization WO2008156725A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93439507P 2007-06-12 2007-06-12
US60/934,395 2007-06-12

Publications (2)

Publication Number Publication Date
WO2008156725A2 WO2008156725A2 (en) 2008-12-24
WO2008156725A3 true WO2008156725A3 (en) 2009-04-23

Family

ID=40156851

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/007485 WO2008156725A2 (en) 2007-06-12 2008-06-16 Methods for inhibiting cartilage mineralization

Country Status (1)

Country Link
WO (1) WO2008156725A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1729675A4 (en) 2004-03-05 2011-05-18 Univ Columbia Multi-phased, biodegradable and osteointegrative composite scaffold for biological fixation of musculoskeletal soft tissue to bone
US8753391B2 (en) 2007-02-12 2014-06-17 The Trustees Of Columbia University In The City Of New York Fully synthetic implantable multi-phased scaffold
US8530420B2 (en) 2008-12-16 2013-09-10 Kaohsiung Medical University Treatment of arthritis with parathyroid hormone
ES2605813B1 (en) * 2015-09-16 2018-01-17 Fundación Instituto De Investigación Sanitaria Fundación Jiménez Díaz USE OF OSTEOSTATIN IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ARTROSIS
US20220298481A1 (en) * 2021-03-19 2022-09-22 Kaohsiung Medical University Method for preparing zonal layered chondrocyte sheets and treating method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175257A1 (en) * 2002-03-12 2003-09-18 Song Sun Uk Cartilage regeneration using chondrocyte and TGF-beta
US20040109845A1 (en) * 2001-03-23 2004-06-10 Robert Terkeltaub Method for inhibiting articular cartilage matrix calcification
US20040122209A1 (en) * 2002-09-30 2004-06-24 Shriners Hospital For Children Products for regulating the degradation of collagen and methods for identifying same
US6787518B1 (en) * 1995-02-20 2004-09-07 Yukio Kato Therapeutics of osteoarthritis and inflammatory joint disease
US20060036331A1 (en) * 2004-03-05 2006-02-16 Lu Helen H Polymer-ceramic-hydrogel composite scaffold for osteochondral repair

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787518B1 (en) * 1995-02-20 2004-09-07 Yukio Kato Therapeutics of osteoarthritis and inflammatory joint disease
US20040109845A1 (en) * 2001-03-23 2004-06-10 Robert Terkeltaub Method for inhibiting articular cartilage matrix calcification
US20030175257A1 (en) * 2002-03-12 2003-09-18 Song Sun Uk Cartilage regeneration using chondrocyte and TGF-beta
US20040122209A1 (en) * 2002-09-30 2004-06-24 Shriners Hospital For Children Products for regulating the degradation of collagen and methods for identifying same
US20060036331A1 (en) * 2004-03-05 2006-02-16 Lu Helen H Polymer-ceramic-hydrogel composite scaffold for osteochondral repair

Also Published As

Publication number Publication date
WO2008156725A2 (en) 2008-12-24

Similar Documents

Publication Publication Date Title
GB0808467D0 (en) Systems, methods and components for water treatment and remediation
EP2023926A4 (en) Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
MX2010006823A (en) Methods for the treatment of gout.
EP1951158A4 (en) Devices and methods for treating facet joints, uncovertebral joints, costovertebral joints and other joints
EP2021911A4 (en) System and method for improving online advertising effectiveness and promoting digital content creation
WO2010020475A3 (en) Method for improving the cleaning action of a detergent or cleaning agent
GB0821294D0 (en) System for product authentication and tracking
WO2009009173A3 (en) Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases
HK1094647A2 (en) System and method for distributing targeted content
WO2010074588A8 (en) Pharmaceutical compounds
WO2009109911A8 (en) Methods of treating chronic pain
WO2008115469A3 (en) Role of hedgehog signaling in atherosclerosis and cardiovascular disease
EP2191383A4 (en) Tracking, correlating, and processing multi-user online sessions
IL172907A0 (en) System and method for promoting advertisement generated revenue via the internet
WO2007109105A3 (en) Flavivirus inhibition by sultams and related compounds
WO2008156725A3 (en) Methods for inhibiting cartilage mineralization
EP1993713A4 (en) System and method for delivering vapor
WO2010052312A8 (en) Drug or dermatological composition containing an avocado peptide extract for treating and preventing pruritus
CL2009000803A1 (en) Use of a pegylated variant of igf-1 to treat, prevent a neuromuscular disorder; method for the treatment, prevention and / or delay of a neuromuscular disorder; composition comprising the modified igf-1 variant
WO2007121124A3 (en) Hcv inhibitors comprising beta amino acids and their uses
EP2381920A4 (en) Methods and compositions for treating p.acnes
WO2010045229A3 (en) Protecting and repairing cartilage and musculoskeletal soft tissues
TWI369590B (en) Treatment liquid for resist substrate, and method of treating resist substrate using the same
ITTO20060500A1 (en) SYSTEM FOR THE DISTRIBUTED PROCESSING OF MULTIMEDIA CONTENT IN COMMUNICATION NETWORKS, IN PARTICULAR OF A DOMESTIC TYPE, RELATED PROCEDURE AND IT PRODUCT
WO2006136933A3 (en) Composition for the treatment and/or prevention of attacks by biological agents

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08779652

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08779652

Country of ref document: EP

Kind code of ref document: A2